Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Sandoz Group Ag (0SAN) Share Price

Price 60.06 on 15-01-2026 at 04:45:17
Change 0.00 0%
Buy 0.00
Sell 0.00
Last Trade: Unknown 3,619.00 at 61.342
Day's Volume: 0
Last Close: 60.06
Open: 0.00
ISIN: CH1243598427
Day's Range 0.00 - 0.00
52wk Range: 30.61 - 60.56
Market Capitalisation: -
VWAP: 0.00
Shares in Issue: 430.70m

Sandoz Group Ag (0SAN) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 3,619 61.342 OTC Trade
18:28:38 - 14-Jan-26
Unknown* 13,454 61.28 OTC Trade
17:47:04 - 14-Jan-26
Unknown* 1,165 61.23796 OTC Trade
17:40:00 - 14-Jan-26
Unknown* 212 61.22765 OTC Trade
17:40:00 - 14-Jan-26
Unknown* 8 60.76608 OTC Trade
17:38:04 - 14-Jan-26
Unknown* 6 60.06 SI Trade
Negotiated Trade
17:35:03 - 14-Jan-26
Unknown* 5,660 61.15788 OTC Trade
17:29:06 - 14-Jan-26
Unknown* 11,298 61.148 OTC Trade
17:29:06 - 14-Jan-26
Unknown* 10,233 61.27755 OTC Trade
17:29:06 - 14-Jan-26
Unknown* 750 61.11837 OTC Trade
17:28:42 - 14-Jan-26
See more Sandoz Group Ag trades

Sandoz Group Ag (0SAN) Share Price History

Time period:
to
Date Open High Low Close Volume
15th Jan 2026 (Thu) 60.06 60.06 60.06 60.06 0
14th Jan 2026 (Wed) 60.06 60.06 60.06 60.06 117,211
13th Jan 2026 (Tue) 59.22 59.22 59.22 59.22 59,057
12th Jan 2026 (Mon) 59.90 59.90 59.90 59.90 27,941
9th Jan 2026 (Fri) 60.56 60.56 60.56 60.56 479,547
8th Jan 2026 (Thu) 60.42667 60.42667 60.42667 60.42667 198,649
7th Jan 2026 (Wed) 60.56 60.56 60.56 60.56 67,999
6th Jan 2026 (Tue) 58.73667 58.73667 58.73667 58.73667 146,460
5th Jan 2026 (Mon) 57.89352 57.89352 57.89352 57.89352 67,597
2nd Jan 2026 (Fri) 57.65531 57.65531 57.65531 57.65531 0
1st Jan 2026 (Thu) 57.65531 57.65531 57.65531 57.65531 0
31st Dec 2025 (Wed) 57.65531 57.65531 57.65531 57.65531 0
30th Dec 2025 (Tue) 57.65531 57.65531 57.65531 57.65531 51,569
29th Dec 2025 (Mon) 57.77142 57.77142 57.77142 57.77142 16,751
26th Dec 2025 (Fri) 58.33361 58.33361 58.33361 58.33361 0
25th Dec 2025 (Thu) 58.33361 58.33361 58.33361 58.33361 0
24th Dec 2025 (Wed) 58.33361 58.33361 58.33361 58.33361 0
23rd Dec 2025 (Tue) 58.33361 58.33361 58.33361 58.33361 48,848
22nd Dec 2025 (Mon) 57.78 57.78 57.78 57.78 15,785
19th Dec 2025 (Fri) 57.61631 57.61631 57.61631 57.61631 270,521
18th Dec 2025 (Thu) 57.61947 57.61947 57.61947 57.61947 66,210
17th Dec 2025 (Wed) 56.92546 56.92546 56.92546 56.92546 57,242
16th Dec 2025 (Tue) 56.73921 56.73921 56.73921 56.73921 311,951
15th Dec 2025 (Mon) 57.8831 57.8831 57.8831 57.8831 733,743
See more Sandoz Group Ag price history

Sandoz Group Ag (0SAN) Regulatory News

Date Source Headline
12th Aug 2025 6:00 am GNW Sandoz launches renewable energy partnership to cover nearly 90% of electricity demand for European operations
7th Aug 2025 6:00 am GNW Sandoz delivers strong H1 2025 results, with accelerated sales growth in the second quarter
30th Jul 2025 6:15 am GNW Sandoz signs non-binding term sheet with Evotec SE to acquire its Just-Evotec Biologics in-house development and manufacturing capabilities in Toulouse, France
1st Jul 2025 1:56 pm GNW Sandoz further asserts leadership in biosimilars, breaking ground on new Slovenia facility to expand European biosimilar hub and global market reach
2nd Jun 2025 6:00 am GNW Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options for over 10 million patients[1]
21st May 2025 4:30 pm GNW Sandoz launches Pyzchiva® autoinjector, first commercially available in Europe for ustekinumab biosimilars
30th Apr 2025 6:00 am GNW Sandoz reports Q1 2025 net sales in line with company expectations; full-year guidance confirmed
29th Apr 2025 4:00 pm GNW Sandoz enters global collaboration license agreement with Henlius to commercialize leading oncology therapy, ipilimumab, in multiple indications
15th Apr 2025 12:50 pm GNW Shareholders approve all resolutions proposed by Board of Directors at Annual General Meeting of Sandoz Group AG
14th Apr 2025 3:00 pm GNW [Corrected] Sandoz files antitrust litigation against Amgen regarding patient access to etanercept biosimilar in the US
See more Sandoz Group Ag regulatory news
FTSE 100 Latest
Value10,184.35
Change47.00

Login to your account

Forgot Password?

Not Registered